3.24.2.u1 html 170 222 1 false 39 0 false 5 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParentheticalUnaudited Condensed Consolidated Balance Sheets (Parenthetical) (Unaudited) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) Sheet http://www.reparerx.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLossUnaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited) Sheet http://www.reparerx.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited Condensed Consolidated Statements of Shareholders' Equity (Unaudited) Statements 5 false false R6.htm 100050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995455 - Disclosure - Organization and Nature of Business Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureOrganizationAndNatureOfBusiness Organization and Nature of Business Notes 9 false false R10.htm 995465 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 10 false false R11.htm 995475 - Disclosure - Cash and Cash Equivalents and Marketable Securities Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureCashAndCashEquivalentsAndMarketableSecurities Cash and Cash Equivalents and Marketable Securities Notes 11 false false R12.htm 995485 - Disclosure - Fair Value Measurements Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 995495 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities Accrued Expenses and Other Current Liabilities Notes 13 false false R14.htm 995505 - Disclosure - Collaborative Arrangements Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureCollaborativeArrangements Collaborative Arrangements Notes 14 false false R15.htm 995515 - Disclosure - Revenue recognition from Collaboration and License Agreements Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureRevenueRecognitionFromCollaborationAndLicenseAgreements Revenue recognition from Collaboration and License Agreements Notes 15 false false R16.htm 995525 - Disclosure - Leases Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureLeases Leases Notes 16 false false R17.htm 995535 - Disclosure - Share-Based Compensation Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensation Share-Based Compensation Notes 17 false false R18.htm 995545 - Disclosure - Net Loss per Share Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureNetLossPerShare Net Loss per Share Notes 18 false false R19.htm 995575 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 19 false false R20.htm 995585 - Disclosure - Cash and Cash Equivalents and Marketable Securities (Tables) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureCashAndCashEquivalentsAndMarketableSecuritiesTables Cash and Cash Equivalents and Marketable Securities (Tables) Tables http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureCashAndCashEquivalentsAndMarketableSecurities 20 false false R21.htm 995595 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurements 21 false false R22.htm 995605 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities 22 false false R23.htm 995615 - Disclosure - Revenue recognition from Collaboration and License Agreements (Tables) Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureRevenueRecognitionFromCollaborationAndLicenseAgreementsTables Revenue recognition from Collaboration and License Agreements (Tables) Tables http://www.reparerx.com/20240630/taxonomy/role/DisclosureRevenueRecognitionFromCollaborationAndLicenseAgreements 23 false false R24.htm 995625 - Disclosure - Leases (Tables) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureLeasesTables Leases (Tables) Tables http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureLeases 24 false false R25.htm 995635 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables Share-Based Compensation (Tables) Tables http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensation 25 false false R26.htm 995645 - Disclosure - Net Loss per Share (Tables) Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureNetLossPerShareTables Net Loss per Share (Tables) Tables http://www.reparerx.com/20240630/taxonomy/role/DisclosureNetLossPerShare 26 false false R27.htm 995675 - Disclosure - Cash and Cash Equivalents and Marketable Securities - Summary of Cash and Cash Equivalents and Marketable Securities (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureCashAndCashEquivalentsAndMarketableSecuritiesSummaryOfCashAndCashEquivalentsAndMarketableSecuritiesDetails Cash and Cash Equivalents and Marketable Securities - Summary of Cash and Cash Equivalents and Marketable Securities (Details) Details 27 false false R28.htm 995685 - Disclosure - Cash and Cash Equivalents and Marketable Securities - Additional Information (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureCashAndCashEquivalentsAndMarketableSecuritiesAdditionalInformationDetails Cash and Cash Equivalents and Marketable Securities - Additional Information (Details) Details 28 false false R29.htm 995695 - Disclosure - Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on a Recurring Basis (Details) Details 29 false false R30.htm 995705 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 30 false false R31.htm 995715 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) Details 31 false false R32.htm 995725 - Disclosure - Collaborative Arrangements - Additional Information (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureCollaborativeArrangementsAdditionalInformationDetails Collaborative Arrangements - Additional Information (Details) Details 32 false false R33.htm 995735 - Disclosure - Revenue recognition from Collaboration and License Agreements - Schedule of Revenue From Collaboration Agreements (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureRevenueRecognitionFromCollaborationAndLicenseAgreementsScheduleOfRevenueFromCollaborationAgreementsDetails Revenue recognition from Collaboration and License Agreements - Schedule of Revenue From Collaboration Agreements (Details) Details 33 false false R34.htm 995745 - Disclosure - Revenue recognition from Collaboration and License Agreements - Additional Information (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureRevenueRecognitionFromCollaborationAndLicenseAgreementsAdditionalInformationDetails Revenue recognition from Collaboration and License Agreements - Additional Information (Details) Details 34 false false R35.htm 995755 - Disclosure - Revenue recognition from Collaboration and License Agreements - Schedule of Deferred Revenue (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureRevenueRecognitionFromCollaborationAndLicenseAgreementsScheduleOfDeferredRevenueDetails Revenue recognition from Collaboration and License Agreements - Schedule of Deferred Revenue (Details) Details 35 false false R36.htm 995765 - Disclosure - Leases - Additional Information (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 36 false false R37.htm 995775 - Disclosure - Leases - Summary of Lease Costs (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseCostsDetails Leases - Summary of Lease Costs (Details) Details 37 false false R38.htm 995785 - Disclosure - Leases - Summary of Other Operating Lease Information (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureLeasesSummaryOfOtherOperatingLeaseInformationDetails Leases - Summary of Other Operating Lease Information (Details) Details 38 false false R39.htm 995795 - Disclosure - Share-Based Compensation - Additional Information (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationAdditionalInformationDetails Share-Based Compensation - Additional Information (Details) Details 39 false false R40.htm 995805 - Disclosure - Share-Based Compensation - Schedule of Share Option Activity (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureSharebasedCompensationScheduleOfShareOptionActivityDetails Share-Based Compensation - Schedule of Share Option Activity (Details) Details 40 false false R41.htm 995815 - Disclosure - Share-Based Compensation - Schedule of Fair Value of Stock Options Determined on Grant Date Using Black Scholes Option-Pricing Model (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationScheduleOfFairValueOfStockOptionsDeterminedOnGrantDateUsingBlackScholesOptionPricingModelDetails Share-Based Compensation - Schedule of Fair Value of Stock Options Determined on Grant Date Using Black Scholes Option-Pricing Model (Details) Details 41 false false R42.htm 995825 - Disclosure - Share-Based Compensation - Summary of Total Outstanding Restricted Stock Units (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureSharebasedCompensationSummaryOfTotalOutstandingRestrictedStockUnitsDetails Share-Based Compensation - Summary of Total Outstanding Restricted Stock Units (Details) Details 42 false false R43.htm 995835 - Disclosure - Share-Based Compensation - Schedule of Share-based Compensation Expense (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationScheduleOfShareBasedCompensationExpenseDetails Share-Based Compensation - Schedule of Share-based Compensation Expense (Details) Details 43 false false R44.htm 995845 - Disclosure - Net Loss per Share - Summary of Basic and Diluted Net Loss per Share Attributable to Common Stockholders (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureNetLossPerShareSummaryOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails Net Loss per Share - Summary of Basic and Diluted Net Loss per Share Attributable to Common Stockholders (Details) Details 44 false false R45.htm 995855 - Disclosure - Net Loss per Share - Computation of Diluted Net Loss Per Share in Attributable to Common Shareholders Indicate to Anti Diluted Effect (Details) Sheet http://www.reparerx.com/20240630/taxonomy/role/DisclosureNetLossPerShareComputationOfDilutedNetLossPerShareInAttributableToCommonShareholdersIndicateToAntiDilutedEffectDetails Net Loss per Share - Computation of Diluted Net Loss Per Share in Attributable to Common Shareholders Indicate to Anti Diluted Effect (Details) Details 45 false false All Reports Book All Reports rptx-20240630.htm rptx-20240630.xsd img194142222_0.jpg http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 false false